Research and Development

Showing 15 posts of 9603 posts found.

New chief executive for Eyevensys

March 26, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys

Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …
mike_williams_leo_pharma

LEO Pharma appoints two divisional directors

March 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma

LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …

Contract research news in brief

March 22, 2013 Research and Development Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv Health

inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.

Budget 2013: pharma ‘pleased’

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK

Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
steven_burrill-headshot-cropped

Targacept makes changes to Board and management

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept

Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …
screen_shot_2013-03-20_at_09

Ziarco appoints John LaMattina as R&D advisor

March 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …

Knee trial for Merck KGaA

March 19, 2013 Research and Development, Sales and Marketing Merck KGaA, knee, nordic

Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …
Astrazeneca image

AstraZeneca restructures global R&D

March 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

Britannia Pharma appoints marketing director

March 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britannia

Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets. …
Witty image

GSK’s Witty: ‘Drugs should be cheaper’

March 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …
screen_shot_2013-03-15_at_10

BASF makes organisational changes

March 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing BASF

Leading chemical firm BASF has made a series of appointments in order to reorganise its business operations. Strengthening the Asia-Pacific …
merck image

Merck makes Alzheimer’s deal

March 14, 2013 Research and Development, Sales and Marketing Alzheimer's, Merck

Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …
J&J image

J&J opens London hub

March 14, 2013 Medical Communications, Research and Development, Sales and Marketing J&J, JJ, London, research

Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …
Aptuit image

MHRA wins data scam case

March 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, MHRA, data

An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …
roche_humer

Roche chairman standing down

March 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer

The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …
The Gateway to Local Adoption Series

Latest content